
crawford.brown@edenbiodesign.com
Crawford co–founded Eden Biodesign in 2000 from Celltech–Medeva where he was Director of Product Development responsible for developing and manufacturing the biotech product pipeline. Among his achievements Crawford managed and led a successful pan–European submission for a complex recombinant vaccine which included an EMEA sponsored pre–approval inspection. Crawford has held senior technical management positions in both biotech and pharmaceutical companies and has been actively engaged in commercial biopharmaceutical development for over 20 years.
As well as leading the company, he retains a major role in Eden Biodesign’s consultancy services.
To find out more information about Eden Biodesign, our services and our track record please contact us to request a copy of our brochure. If you would like one of our team to get in touch, please submit your details via our registration form.